Acorda Therapeutics reported $45.26M in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acadia Pharmaceuticals ACAD:US $ 3.91B 222.46M
Acorda Therapeutics ACOR:US $ 45.26M 955.08K
Agios Pharmaceuticals AGIO:US $ 3.39B 211.72M
Alexion Pharmaceuticals ALXN:US $ 33.78B 393.15M
ALKERMES ALKS:US 3.93B 959.72M
Amgen AMGN:US $ 140.05B 3.22B
Anika Therapeutics ANIK:US $ 623M 38.49M
Aptinyx Inc APTX:US $ 192.93M 7.74M
Arrowhead Research ARWR:US $ 8.62B 1.74B
Biogen BIIB:US $ 52.13B 9.52B
Biomarin Pharmaceutical BMRN:US $ 15.25B 1.45B
Cara Therapeutics CARA:US $ 714.24M 368.58M
Clovis Oncology CLVS:US $ 606.48M 127.32M
Cytokinetics CYTK:US $ 1.42B 244.24M
Enanta Pharmaceuticals ENTA:US $ 888.79M 106.09M
Gilead Sciences GILD:US $ 86.36B 4.99B
GlaxoSmithKline GSK:LN 71.42B 6.62B
Gw Pharmaceuticals GWPH:US 6.44B 2.84B
Halozyme Therapeutics HALO:US $ 6.47B 491.5M
Heron Therapeutics HRTX:US $ 1.58B 98.85M
Insmed INSM:US $ 3.22B 293.47M
Ligand Pharmaceuticals LGND:US $ 2.18B 347.98M
Mannkind MNKD:US $ 1.36B 384.05M
Merck MRK:GR 20.9B 2.08B
Moderna Inc MRNA:US $ 94.35B 41.95B
Neurocrine Biosciences NBIX:US $ 9.2B 7.62M
Novartis NOVN:VX 208.02B 8.76B
Pfizer PFE:US $ 219205.69M 17108.81M
Sanofi SAN:FP 111.4B 5.33B
Teva Pharmaceutical TEVA:IT 35.79B 6.09B
Ultragenyx Pharmaceutical RARE:US $ 6.43B 1.19B
Vertex Pharmaceuticals VRTX:US $ 52.2B 3.42B